In development
Verada Healthcare IT
Data is not evidence until someone will accept it.
A rehabilitation session generates a great deal of information. Almost none of it survives contact with a regulator, a sponsor's data management team or a commissioner's business case, because it was never captured in a form built to be relied on. This is the layer that fixes that, and it is the reason the rest of Verada is saleable.
The Problem
Most clinical data fails at the point it matters
The failure is rarely in the measurement. It is in everything around it: provenance, immutability, structure and the ability to answer, months later, exactly what happened in a given session and who changed what.
1
Editable outputs
Session reports produced as documents a clinician can amend after the fact are not source records. A sponsor's data management team will identify that in minutes, and it disqualifies the dataset.
2
Unlogged overrides
Clinically sensible features, such as adjusting a calibration value or disabling a sensor with poor contact, are silent data manipulations unless the system records that they happened, when, and by whom.
3
Trapped structure
Data locked in device-specific formats or PDFs cannot be pooled, compared across technologies, or delivered in the shape an analyst needs. It becomes an archive rather than an asset.
The whole proposition of an operator-generated evidence business is "we can prove it." That claim is only as good as the record underneath it.
What It Does
Four functions
Capture
Multimodal, at source. Device signal, clinician-entered assessment, patient-reported measures and operational metadata (session timing, staff grade, completion) brought together as a single session record rather than four disconnected systems.
Assure
Provenance and immutability. Attributable, contemporaneous, original and accurate records with a complete audit trail of every change, override and disabled channel. Built to the standards regulated research already requires.
Structure
Evidence-ready output. Machine-readable export in the shape an analyst, a statistician or a submission actually needs. Device-agnostic and vendor-agnostic, so evidence can be pooled across technologies rather than siloed by manufacturer.
Characterise
Cohort identification. Finding and describing real-world patient populations from routine health records, for feasibility assessment, site selection, and understanding who a technology is actually likely to help.
Design Principles
What we are building toward
Non-negotiable
Governance is the product, not a feature
An evidence platform that is convenient but not defensible has no value. These constraints come first and shape everything else.
- Data protection by design: documented impact assessments, minimisation, and lawful basis established at collection rather than retrofitted
- Consent architecture that anticipates secondary research use, because it cannot be obtained retrospectively
- Full audit trail on every record, every amendment, every export
- Interoperability: semantic and syntactic, so records mean the same thing across systems
- Separation of regimes: regulated research, service evaluation and routine care held to their own standards rather than a blended one
Deliberately not
What we are not building
Restraint here is what keeps the platform buildable by a small team on a real timeline.
- Not an electronic health record. We integrate with clinical systems rather than replacing them
- Not a diagnostic. The platform structures and presents measurement; clinical interpretation stays with clinicians
- Not a general analytics suite. Narrow scope, built around rehabilitation evidence, deep rather than broad
- Not an autonomous decision system. Models support human judgement and are documented as such
Who It Serves
Internal first, licensable later
The platform earns its place by making the other two divisions work. Its external value follows from that, and not before.
Rehab Clinics
Turns routine treatment into an operational and economic dataset (utilisation, throughput, cost per session, completion) without adding administrative burden to clinical staff.
Clinical Research
Provides the audit trail, provenance and structured export that make instrumented delivery usable in a sponsor's study rather than merely interesting.
Manufacturers
Post-market clinical follow-up is a standing regulatory obligation. A platform that produces it as a by-product of care is considerably cheaper than commissioning it as a project.
Other providers
The eventual product. Packaging the protocols, instrumentation standard and data layer so that other clinics can deliver to the same standard. That is how one site becomes a national capability without building fifty clinics.
Where We Are
Honest status
Stage
Earliest of the three divisions. In development, with no external customers and none claimed. It will be proven internally on our own clinical service before it is offered to anyone else.
Sequence
Capture and audit first, because they are the prerequisite for everything downstream. Cohort characterisation and analytics follow once there is a real dataset to work on.
Governance foundation
A Trust-level data protection impact assessment has been completed, and data protection expertise sits within the leadership team rather than being outsourced.
What we will not claim
Any regulatory clearance, assurance standard or certification we do not hold. Where a claim requires an assessment we have not completed, we say so.
The Rest Of The Group
What sits alongside
The platform has no independent value. It exists because two operating businesses need it, and it is built against their real requirements rather than a specification written in the abstract.
Building in this space?
If you work on health data interoperability, evidence infrastructure or real-world data in rehabilitation, we would be glad to compare notes.
Start a conversation →
About this division. Verada Healthcare IT is a trading division of Verada Health Ltd, registered in England & Wales under company number 17137766. It is not currently a separate legal entity. Verada Health Ltd intends to incorporate its divisions as separate companies within the Verada group as each reaches operational scale. Nothing on this page is an offer or invitation to invest, and statements about future plans, timelines and technical capability are targets rather than commitments. See our
Terms of Use.
